HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Jubilant Pharmova’s arm gets 9 observations for Canada facility after USFDA audit
Nov-05-2025

U.S. Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s arm -- Jubilant HollisterStier General Partnership (JHSGP)’s contract manufacturing facility located in Montreal, Canada on November 3, 2025. 

The USFDA has issued 9 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations. JHSGP is jointly owned by subsidiaries of Jubilant Pharma, a wholly owned subsidiary of the company. 

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

  RELATED NEWS >>